NY
Vaccibody (Nykode)
NYKD.OL·OSEOslo NOFounded 200780 employees
Micro CapbiotechPublicOncologyInfectious Disease
Platform: VB10.NEO DNA
Market Cap
$0.15B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (NYKD.OL)
Loading NYKD.OL stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Sovasacituzumab | NYK-2583 | Phase 2/3 | 2 | BET | CeliacPBC | ||
| NYK-4396 | NYK-4396 | Preclinical | 1 | PD-L1 | Hemophilia ALGS |
SEC Filings & Financial Documents
SEC filings are not available for OSE-listed companies.
Vaccibody (Nykode) trades on OSE (NO). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)